Trends In Distributed Artificial Intelligence
Professor Delibegovic worked alongside sector partners, Vertebrate Antibodies and colleagues in NHS Grampian to develop the new tests applying the innovative antibody technology known as Epitogen. As the virus mutates, current antibody tests will become even less accurate therefore the urgent will need for a novel method to incorporate mutant strains into the test-this is precisely what we have achieved. Funded by the Scottish Government Chief Scientist Workplace Rapid Response in COVID-19 (RARC-19) research plan, the team utilised artificial intelligence known as EpitopePredikt, to determine specific elements, or 'hot spots' of the virus that trigger the body's immune defense. Importantly, this method is capable of incorporating emerging mutants into the tests therefore enhancing the test detection rates. This approach enhances the test's overall performance which indicates only relevant viral components are incorporated to let improved sensitivity.